BR
Balaji Ramamurthy
About Balaji Ramamurthy
Data last updated:
Balaji Ramamurthy is a Whole-Time Director at Regenix Drugs Limited (since 2022) and Director at Regenix Biosciences Limited (since 2023). The companies operate in Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹195 Cr; the largest is Regenix Drugs Limited at ₹188 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Regenix Drugs Limited U24232TN2007PLC063446 | Whole-Time Director | 01 Oct 2022 | 2007 | ₹188 Cr (FY 2024) | Active |
 Regenix Biosciences Limited U24100TN2006PLC059065 | Director | 24 Sep 2023 | 2006 | ₹6.81 Cr (FY 2025) | Active |
Board colleagues of Balaji Ramamurthy
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Balaji Ramamurthy
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Balaji Ramamurthy
Balaji Ramamurthy currently holds 2 directorships: Regenix Drugs Limited (Whole-Time Director, since 01 Oct 2022, revenue ₹188 Cr (FY 2024)); Regenix Biosciences Limited (Director, since 24 Sep 2023, revenue ₹6.81 Cr (FY 2025)).
Balaji Ramamurthy was first appointed on 01 Oct 2022 as Whole-Time Director at Regenix Drugs Limited. The most recent appointment on record is 24 Sep 2023 at Regenix Biosciences Limited.
The 2 current companies of Balaji Ramamurthy that report revenue have a combined latest revenue of ₹195 Cr: Regenix Drugs Limited ₹188 Cr (FY 2024); Regenix Biosciences Limited ₹6.81 Cr (FY 2025).
The current boards of Balaji Ramamurthy's companies include Akshay Arvind (Regenix Drugs Limited), Ayyamperumal (Regenix Drugs Limited), Govindarajan Venkatakrishna (Regenix Drugs Limited), Guhan Ramamurthy (Regenix Drugs Limited), Gunasekaran Raju (Regenix Drugs Limited), Krishanamoorthy Nirosha (Regenix Drugs Limited), among others.